Sean Brynjelsen - Feb 7, 2022 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
President & CEO, Director
Signature
/s/ W. Wilson Troutman
Stock symbol
ETON
Transactions as of
Feb 7, 2022
Transactions value $
$0
Form type
4
Date filed
2/28/2022, 03:27 PM
Previous filing
Aug 20, 2021
Next filing
Jul 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETON Stock Option(Right to buy) Award $0 +417K +35.15% $0.00 1.6M Feb 7, 2022 Common Stock 417K $3.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on February 7, 2024.